Quantitative Susceptibility Mapping in Parkinson's Disease.
<h4>Background</h4>Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD). However, the findings in other subcortical deep gray matter nuclei a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162460&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850232427483496448 |
|---|---|
| author | Christian Langkammer Lukas Pirpamer Stephan Seiler Andreas Deistung Ferdinand Schweser Sebastian Franthal Nina Homayoon Petra Katschnig-Winter Mariella Koegl-Wallner Tamara Pendl Eva Maria Stoegerer Karoline Wenzel Franz Fazekas Stefan Ropele Jürgen Rainer Reichenbach Reinhold Schmidt Petra Schwingenschuh |
| author_facet | Christian Langkammer Lukas Pirpamer Stephan Seiler Andreas Deistung Ferdinand Schweser Sebastian Franthal Nina Homayoon Petra Katschnig-Winter Mariella Koegl-Wallner Tamara Pendl Eva Maria Stoegerer Karoline Wenzel Franz Fazekas Stefan Ropele Jürgen Rainer Reichenbach Reinhold Schmidt Petra Schwingenschuh |
| author_sort | Christian Langkammer |
| collection | DOAJ |
| description | <h4>Background</h4>Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD). However, the findings in other subcortical deep gray matter nuclei are converse and the sensitivity of QSM and R2* for morphological changes and their relation to clinical measures of disease severity has so far been investigated only sparsely.<h4>Methods</h4>The local ethics committee approved this study and all subjects gave written informed consent. 66 patients with idiopathic Parkinson's disease and 58 control subjects underwent quantitative MRI at 3T. Susceptibility and R2* maps were reconstructed from a spoiled multi-echo 3D gradient echo sequence. Mean susceptibilities and R2* rates were measured in subcortical deep gray matter nuclei and compared between patients with PD and controls as well as related to clinical variables.<h4>Results</h4>Compared to control subjects, patients with PD had increased R2* values in the substantia nigra. QSM also showed higher susceptibilities in patients with PD in substantia nigra, in the nucleus ruber, thalamus, and globus pallidus. Magnetic susceptibility of several of these structures was correlated with the levodopa-equivalent daily dose (LEDD) and clinical markers of motor and non-motor disease severity (total MDS-UPDRS, MDS-UPDRS-I and II). Disease severity as assessed by the Hoehn & Yahr scale was correlated with magnetic susceptibility in the substantia nigra.<h4>Conclusion</h4>The established finding of higher R2* rates in the substantia nigra was extended by QSM showing superior sensitivity for PD-related tissue changes in nigrostriatal dopaminergic pathways. QSM additionally reflected the levodopa-dosage and disease severity. These results suggest a more widespread pathologic involvement and QSM as a novel means for its investigation, more sensitive than current MRI techniques. |
| format | Article |
| id | doaj-art-266c69e7dbcd4c25aa12ecacfdff9995 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-266c69e7dbcd4c25aa12ecacfdff99952025-08-20T02:03:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016246010.1371/journal.pone.0162460Quantitative Susceptibility Mapping in Parkinson's Disease.Christian LangkammerLukas PirpamerStephan SeilerAndreas DeistungFerdinand SchweserSebastian FranthalNina HomayoonPetra Katschnig-WinterMariella Koegl-WallnerTamara PendlEva Maria StoegererKaroline WenzelFranz FazekasStefan RopeleJürgen Rainer ReichenbachReinhold SchmidtPetra Schwingenschuh<h4>Background</h4>Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD). However, the findings in other subcortical deep gray matter nuclei are converse and the sensitivity of QSM and R2* for morphological changes and their relation to clinical measures of disease severity has so far been investigated only sparsely.<h4>Methods</h4>The local ethics committee approved this study and all subjects gave written informed consent. 66 patients with idiopathic Parkinson's disease and 58 control subjects underwent quantitative MRI at 3T. Susceptibility and R2* maps were reconstructed from a spoiled multi-echo 3D gradient echo sequence. Mean susceptibilities and R2* rates were measured in subcortical deep gray matter nuclei and compared between patients with PD and controls as well as related to clinical variables.<h4>Results</h4>Compared to control subjects, patients with PD had increased R2* values in the substantia nigra. QSM also showed higher susceptibilities in patients with PD in substantia nigra, in the nucleus ruber, thalamus, and globus pallidus. Magnetic susceptibility of several of these structures was correlated with the levodopa-equivalent daily dose (LEDD) and clinical markers of motor and non-motor disease severity (total MDS-UPDRS, MDS-UPDRS-I and II). Disease severity as assessed by the Hoehn & Yahr scale was correlated with magnetic susceptibility in the substantia nigra.<h4>Conclusion</h4>The established finding of higher R2* rates in the substantia nigra was extended by QSM showing superior sensitivity for PD-related tissue changes in nigrostriatal dopaminergic pathways. QSM additionally reflected the levodopa-dosage and disease severity. These results suggest a more widespread pathologic involvement and QSM as a novel means for its investigation, more sensitive than current MRI techniques.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162460&type=printable |
| spellingShingle | Christian Langkammer Lukas Pirpamer Stephan Seiler Andreas Deistung Ferdinand Schweser Sebastian Franthal Nina Homayoon Petra Katschnig-Winter Mariella Koegl-Wallner Tamara Pendl Eva Maria Stoegerer Karoline Wenzel Franz Fazekas Stefan Ropele Jürgen Rainer Reichenbach Reinhold Schmidt Petra Schwingenschuh Quantitative Susceptibility Mapping in Parkinson's Disease. PLoS ONE |
| title | Quantitative Susceptibility Mapping in Parkinson's Disease. |
| title_full | Quantitative Susceptibility Mapping in Parkinson's Disease. |
| title_fullStr | Quantitative Susceptibility Mapping in Parkinson's Disease. |
| title_full_unstemmed | Quantitative Susceptibility Mapping in Parkinson's Disease. |
| title_short | Quantitative Susceptibility Mapping in Parkinson's Disease. |
| title_sort | quantitative susceptibility mapping in parkinson s disease |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162460&type=printable |
| work_keys_str_mv | AT christianlangkammer quantitativesusceptibilitymappinginparkinsonsdisease AT lukaspirpamer quantitativesusceptibilitymappinginparkinsonsdisease AT stephanseiler quantitativesusceptibilitymappinginparkinsonsdisease AT andreasdeistung quantitativesusceptibilitymappinginparkinsonsdisease AT ferdinandschweser quantitativesusceptibilitymappinginparkinsonsdisease AT sebastianfranthal quantitativesusceptibilitymappinginparkinsonsdisease AT ninahomayoon quantitativesusceptibilitymappinginparkinsonsdisease AT petrakatschnigwinter quantitativesusceptibilitymappinginparkinsonsdisease AT mariellakoeglwallner quantitativesusceptibilitymappinginparkinsonsdisease AT tamarapendl quantitativesusceptibilitymappinginparkinsonsdisease AT evamariastoegerer quantitativesusceptibilitymappinginparkinsonsdisease AT karolinewenzel quantitativesusceptibilitymappinginparkinsonsdisease AT franzfazekas quantitativesusceptibilitymappinginparkinsonsdisease AT stefanropele quantitativesusceptibilitymappinginparkinsonsdisease AT jurgenrainerreichenbach quantitativesusceptibilitymappinginparkinsonsdisease AT reinholdschmidt quantitativesusceptibilitymappinginparkinsonsdisease AT petraschwingenschuh quantitativesusceptibilitymappinginparkinsonsdisease |